Abstract
Type 1 diabetes mellitus (T1DM) results in autoimmune destruction of insulin producing pancreatic beta cells. Although thought to be terminally differentiated, beta cells may undergo expansion during pregnancy. As pregnancy creates a state of immune tolerance, exploring this finding may offer insights to possible therapies for T1DM. We investigated whether circulating factors in serum from pregnant women could reduce the degree of immune activation of human T cells specific for beta cell antigens by measuring interleukin-2 (IL-2).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
